JP2022540433A5 - - Google Patents
Info
- Publication number
- JP2022540433A5 JP2022540433A5 JP2022500796A JP2022500796A JP2022540433A5 JP 2022540433 A5 JP2022540433 A5 JP 2022540433A5 JP 2022500796 A JP2022500796 A JP 2022500796A JP 2022500796 A JP2022500796 A JP 2022500796A JP 2022540433 A5 JP2022540433 A5 JP 2022540433A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- benzo
- pentyl
- chromen
- trimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962873697P | 2019-07-12 | 2019-07-12 | |
| US62/873,697 | 2019-07-12 | ||
| PCT/CA2020/050965 WO2021007659A1 (en) | 2019-07-12 | 2020-07-10 | Cannabinoid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022540433A JP2022540433A (ja) | 2022-09-15 |
| JP2022540433A5 true JP2022540433A5 (enExample) | 2025-02-14 |
Family
ID=74209629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500796A Ceased JP2022540433A (ja) | 2019-07-12 | 2020-07-10 | カンナビノイド誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220242856A1 (enExample) |
| EP (1) | EP3997084A4 (enExample) |
| JP (1) | JP2022540433A (enExample) |
| WO (1) | WO2021007659A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3994114A4 (en) | 2019-07-04 | 2023-08-16 | Canopy Growth Corporation | CANNABINOID DERIVATIVES |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3997098A4 (en) | 2019-07-12 | 2023-10-11 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007661A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| WO2021062557A1 (en) * | 2019-10-02 | 2021-04-08 | Canopy Growth Corporation | Cannabinoid derivatives |
| US12084407B2 (en) | 2019-11-26 | 2024-09-10 | Canopy Growth Corporation | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
| US12617765B2 (en) | 2019-12-09 | 2026-05-05 | Canopy Growth Corporation | Cannabinoid derivatives |
| IL312785B2 (en) | 2020-05-19 | 2026-06-01 | Cybin Irl Ltd | Deuterated tryptamine derivatives and methods of use |
| AU2021400338A1 (en) | 2020-12-17 | 2023-07-13 | Nalu Bio, Inc. | Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use |
| EP4436559A4 (en) | 2021-11-27 | 2025-04-02 | Miralogx LLC | SYNTHETIC CANNABINOID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT |
| US12636296B1 (en) | 2025-07-17 | 2026-05-26 | Nalu Bio, Inc. | Cannabinol analogs and their use as pharmacologically active agents |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3325490A (en) * | 1965-02-23 | 1967-06-13 | Rexall Drug Chemical | Substituted 1-hydroxydibenzopyrans |
| US20080064679A1 (en) * | 2004-06-24 | 2008-03-13 | Martin Billy R | Water Soluble Cannabinoids |
| AU2007248760A1 (en) * | 2006-05-01 | 2007-11-15 | Eastern Virginia Medical School | Novel cannabinoids and methods of use |
| WO2019234728A1 (en) * | 2018-06-04 | 2019-12-12 | Al&Am Pharmachem Ltd. | Cannabinolic acid derivatives and uses thereof |
-
2020
- 2020-07-10 WO PCT/CA2020/050965 patent/WO2021007659A1/en not_active Ceased
- 2020-07-10 JP JP2022500796A patent/JP2022540433A/ja not_active Ceased
- 2020-07-10 EP EP20838885.0A patent/EP3997084A4/en active Pending
- 2020-07-10 US US17/626,512 patent/US20220242856A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023503331A5 (enExample) | ||
| JP2022540586A5 (enExample) | ||
| AU2013234009B2 (en) | Heterocyclyl compounds as MEK inhibitors | |
| ES2759949T3 (es) | Compuestos heterocíclicos tricíclicos | |
| KR101345473B1 (ko) | 헤테로 화합물 | |
| JP2022539401A5 (enExample) | ||
| JP2022540432A5 (enExample) | ||
| EP2382212B1 (en) | Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases | |
| BRPI0707427A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, método para tratar dislipidemia, aterosclerose, e diabetes e complicações da mesma, para elevar os nìveis plásmicos de hdl, e para diminuir triglicerìdeos plásmicos, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
| JP2022551067A5 (enExample) | ||
| CA2741839A1 (en) | 1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors | |
| JP2022540585A5 (enExample) | ||
| WO2010065760A1 (en) | Imidazo [1,2a] pyridine derivatives, their use as s1p1 agonists and methods for their production | |
| JP2022540434A5 (enExample) | ||
| WO2010068452A1 (en) | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase | |
| JP2012515788A (ja) | 自己免疫疾患および炎症性疾患の処置における、ｓ１ｐアゴニストとしての置換オキサジアゾール誘導体 | |
| HRP20171099T1 (hr) | Derivati pirolo[2,3-d]pirimidina kao agonisti cb2 receptora | |
| JP2013514280A (ja) | スフィンゴシン１−リン酸１（ｓ１ｐ１）受容体アゴニストとして使用するためのオキサジアゾール置換インダゾール誘導体 | |
| AU2014352008B2 (en) | Tricyclic piperidine compounds | |
| ES2548683T3 (es) | Amidas del ácido 4-(5-isoxazolil o 5-pirrazolil-1,2,4-oxadiazol-3-il)-mandélico como agonistas de receptor de esfingosina-1-fosfato 1 | |
| KR20160129089A (ko) | 신규의 융합된 이미다조벤조티아졸 화합물 | |
| TW202233575A (zh) | 用於治療與lpa受體活性相關的病狀的化合物及組合物 | |
| EP3071567A1 (en) | Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase | |
| EP2941427B1 (fr) | Nouveaux dérivés benzodioxane-piperidine et leurs applications thérapeutiques pour le traitement des affections neuropsychiatriques | |
| WO2023032940A1 (ja) | 含窒素三環性化合物及びその医薬用途 |